Articles les plus consultés

vendredi 20 avril 2018

FDA advisors back approval of GW’s Epidiolex

FDA advisors back approval of GW’s Epidiolex

Digirad Corporation to Release 2018 First Quarter Financial Results on May 1, 2018

Digirad Corporation to Release 2018 First Quarter Financial Results on May 1, 2018: Conference Call and Webcast Set for 11:00 a.m. EDT

Allergan à l'extérieur mais Takeda colle aux armes sur Shire | Pharmafile

Allergan à l'extérieur mais Takeda colle aux armes sur Shire | Pharmafile

BONJOUR


ARGS Hit By Double Whammy, GWPH's Epidiolex Nears Approval, FDA Nod For AZN

ARGS Hit By Double Whammy, GWPH's Epidiolex Nears Approval, FDA Nod For AZN